Compare iShares Russell 2000 ETF (IWM) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Russell 2000 ETF vs Twist Bioscience Corp — how do they compare? iShares Russell 2000 ETF trades at $296.22, while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: iShares Russell 2000 ETF is trading nearer its 52-week high, Twist Bioscience Corp nearer its low. Which is the better fit depends on your goals.
| IWM | TWST | |
|---|---|---|
52-Week High | $300.45 | $102.88 |
52-Week Low | $214.95 | $24.16 |
Market Cap | — | $5.45B |
Sector | — | Health |
Enterprise Value | — | $5.37B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IWM, tracking the Russell 2000 small-cap index, trades at $292.34, down 0.6% on the day. Technical indicators show a bullish bias with moving averages supporting an uptrend, while oscillators are neutral. Recent news highlights strong small-cap outperformance, with the Russell 2000 up approximately 20% year-to-date, fueled by institutional inflows and a shifting interest rate outlook.
The outlook for IWM is positive, driven by potential for continued small-cap leadership amid economic expansion and lower rate expectations. Key risks include higher volatility relative to large-caps and sensitivity to broader economic conditions. The ETF offers diversified exposure to nearly 2,000 small-cap stocks, but investors should weigh its 0.19% expense ratio against alternatives.
TWST trades at $95.86, up 2.14% today, with a bullish technical signal and strong institutional interest. Revenue growth is robust, rising from $204M in 2022 to $377M in 2025, though the company remains unprofitable with a net income margin of -19.85%. Recent news highlights AI-driven collaborations and earnings beats, but cash flow trends show persistent operational losses.
The outlook is mixed; analyst consensus is bullish with a $91.63 price target, but profitability challenges and negative cash flows pose significant risks. Investment opportunity lies in continued revenue expansion and AI partnerships, while execution risks and high valuations require caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Russell 2000 ETF
The ETF is designed to track the performance of the securities and the stocks in the Russell 2000 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on IWM →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
